Colombo J
Parasympathetic & Sympathetic Nervous System Consultant, Franklin Cardiovascular Associates, PA and Autonomic Dysfunction and POTS Center; Neurocardiology Research Corporation, LLC, Wilmington, DE, USA
Publications
-
Research Article
Antioxidants Effect Changes in Systemic Parasympathetic and Sympathetic Nervous System Responses and Improve Outcomes
Author(s): Acosta CR, DePace NL, DePace NL, Kaczmarski K, Pinales JM and Colombo J*
Parasympathetic and Sympathetic (P&S) imbalance is associated with increased morbidity and mortality risk, including heart failure, coronary artery disease, atrial and ventricular arrhythmias, hypertension and orthostatic disorders, and syncope. Most cardiac medications effect only one or the other of the P&S nervous systems, including: β-blockers, α-blockers, α-agonists, and anti-cholinergics. Non-pharmaceutical treatments also affect the P&S nervous systems; however, nonpharmaceutical treatment is rarely addressed or studied, despite significant evidence-based data demonstrating normalization of Sympathovagal Balance. Fifty consecutive patients from a busy suburban cardiology practice were enrolled in a supplement study. Patients were provided supplements that included 200mg of Alpha-Lipoic Acid (ALA) and 100mg of Co-Enzyme Q10 (CoQ10) which they were in.. Read More»